We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “Immunotherapy with checkpoint inhibitors is currently ...
Interleukin-6 (IL-6) occupies a central yet paradoxical position in the metabolic landscape of obesity. Originally characterised as a pro-inflammatory cytokine, IL-6 has since been recognised for its ...
Researchers have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6). Researchers at The University of Texas ...
Effect of probiotics on quality of life for patients with cancer undergoing immunotherapy. Clinical improvement by irAEs type (Test for subgroup differences, p < 0.01).
CI denotes confidence interval, and SNP single-nucleotide polymorphism. Sequencing reads were aligned to the hg19 reference genome. A SIFT (sorting intolerant from tolerant) score of less than 0.05 ...
However, imbalances of IL-6 — too much or too little — can cause disease, even in the absence of infection. Excess IL-6 is central to the pathogenesis of inflammatory reactions like rheumatoid disease ...
Interleukin-6 (IL-6) is a pleiotropic cytokine that may play a role in the regulation of various aspects of the immune response, inflammation, hematopoiesis, and bone metabolism. IL-6 acts by binding ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine ...
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results